CASE REPORT
A 41-year-old woman was admitted for hemoptysis of 4 days' duration. Her medical and family history was unremarkable. She visited a local clinic, where a chest radiograph revealed a radio-opaque mass in the right upper lung Immunohistochemical staining for CD 99 revealed diffuse membranous positivity in the tumor cells, which is a characteristic feature of Ewing's sarcoma (Fig. 3) . Immunohisto- The pathological diagnosis of extraosseous Ewing's sarcoma used to require the use of both standard light and electron microscopy to identify small, round, blue cells with abundant glycogen and an absence of cytoplasmic filaments. Because of the lack of any specific morphologic features or diagnostic histopathologic finding, the rate of misdiagnosis by histopathologic findings alone is exceptionally high [5] . Therefore, we used a more accurate diagnostic method, immunohistochemical staining. Staining for CD99 (a cell-surface glycoprotein encoded by the MIC2 gene) has recently been used for the identification of Ewing's sarcoma, although it is not entirely specific for this disease [6] . Ewing's sarcoma should be differentiated from small-cell carcinoma, adenocarcinoma, squamous cell carcinoma, squamous cell carcinoma, and lymphoma. The cells in this case were small and round, as described above, and immunohistochemistry showed strong staining for CD99 Therefore, we readily diagnosed the case as Ewing's sarcoma. RT-PCR was not performed in this case because we had already diagnosed Ewing's sarcoma on the basis of the immunohistochemical staining results. Extraosseous Ewing's sarcoma is a curable disease. The disease-free survival rate has been significantly increased by managing these tumors with aggressive surgical resection in combination with multi-agent chemotherapy, with or without radiotherapy [7] .
Currently, most protocols recommend surgical resection rather than radiation therapy if possible and reserve the use of postoperative radiation for positive margins or residual disease [8] . The 5-year disease-free survival rate is estimated to be 60% to 70% for localized disease managed with multi-agent chemotherapy and surgical resection [7] .
In summary, we experienced a case of primary pulmonary Ewing's sarcoma. The patient underwent right upper lung lobectomy and postoperative chemoradiotherapy. She has exhibited no sign of recurrence to date; therefore, we report this as an outcome of the treatment of primary pulmonary Ewing's sarcoma with surgical resection and combination therapy.
